Squarepoint’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.49M Sell
89,060
-576,737
-87% -$9.67M ﹤0.01% 1298
2025
Q1
$10.2M Buy
665,797
+353,168
+113% +$5.43M 0.01% 544
2024
Q4
$6.89M Buy
312,629
+297,031
+1,904% +$6.55M 0.01% 647
2024
Q3
$281K Buy
+15,598
New +$281K ﹤0.01% 2033
2023
Q3
Sell
-313,436
Closed -$2.36M 2857
2023
Q2
$2.36M Buy
313,436
+287,547
+1,111% +$2.17M 0.01% 831
2023
Q1
$229K Buy
+25,889
New +$229K ﹤0.01% 1804
2022
Q3
Sell
-46,262
Closed -$348K 2514
2022
Q2
$348K Sell
46,262
-48,025
-51% -$361K ﹤0.01% 1515
2022
Q1
$885K Sell
94,287
-394
-0.4% -$3.7K ﹤0.01% 1198
2021
Q4
$758K Sell
94,681
-262,867
-74% -$2.1M ﹤0.01% 1367
2021
Q3
$3.48M Buy
357,548
+255,708
+251% +$2.49M 0.01% 595
2021
Q2
$1.01M Sell
101,840
-558,269
-85% -$5.53M ﹤0.01% 1169
2021
Q1
$7.62M Buy
660,109
+554,855
+527% +$6.4M 0.04% 308
2020
Q4
$1.02M Buy
+105,254
New +$1.02M 0.01% 1068
2020
Q3
Sell
-122,418
Closed -$1.51M 2673
2020
Q2
$1.51M Buy
+122,418
New +$1.51M 0.02% 734
2020
Q1
Sell
-80,508
Closed -$789K 2432
2019
Q4
$789K Sell
80,508
-17,965
-18% -$176K ﹤0.01% 1459
2019
Q3
$677K Sell
98,473
-97,508
-50% -$670K 0.01% 1413
2019
Q2
$1.81M Buy
195,981
+65,458
+50% +$604K 0.02% 889
2019
Q1
$2.05M Buy
130,523
+91,205
+232% +$1.43M 0.02% 762
2018
Q4
$606K Sell
39,318
-34,398
-47% -$530K 0.01% 1141
2018
Q3
$1.59M Buy
73,716
+50,713
+220% +$1.09M 0.02% 805
2018
Q2
$559K Buy
+23,003
New +$559K 0.01% 1143
2017
Q4
Sell
-73,361
Closed -$1.29M 2326
2017
Q3
$1.29M Buy
+73,361
New +$1.29M 0.02% 628